01 May 2012 11:47 [Source: ICIS news]
LONDON (ICIS)--Huntsman’s first-quarter net income more than doubled year on year to $163m (€124m) from $62m on the back of higher sales, the US-based chemicals major said on Tuesday.
Revenues for the three months ended 31 March 2012 grew 8.73% year on year to $2.91bn, while adjusted earnings before interest, tax depreciation and amortisation (EBITDA) rose to $397m from $304m in the same period in 2011, Huntsman added.
CEO Peter Huntsman said: “Our first quarter 2012 earnings represented a record performance. Improvements in our [methyl diphenyl diisocyanate] MDI selling prices and attractive margins in our [propylene oxide methyl tertiary butyl ether] POMTBE business were notable”.
“There are still considerable financial benefits forthcoming from our restructuring efforts. Notwithstanding certain economic challenges in various parts of the world, I am most optimistic about our earnings potential,” he added.
($1 = €0.76)
For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.
Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.
|ICIS news FREE TRIAL|
|Get access to breaking chemical news as it happens.|
|ICIS Global Petrochemical Index (IPEX)|
|ICIS Global Petrochemical Index (IPEX). Download the free tabular data and a chart of the historical index|